Abstract
Molecular Pharming represents an unprecedented opportunity to manufacture affordable modern medicines and make these available at a global scale. The area of greatest potential is in the prevention of infectious diseases, particular in underdeveloped countries where access to medicines and vaccines has historically been limited. This is why, at St. George's, we focus on diseases such as HIV, TB and rabies, and aim to develop production strategies that are simple and potentially easy to transfer to developing countries.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
AIDS Vaccines / biosynthesis
-
Adjuvants, Immunologic / biosynthesis
-
Animals
-
Antibodies, Monoclonal / biosynthesis
-
Antigen-Antibody Complex / immunology
-
Clinical Trials as Topic / methods
-
Developing Countries
-
Drug Approval
-
Drug Industry
-
Humans
-
Hydroponics
-
Intellectual Property
-
Mice
-
Molecular Farming / methods*
-
Plant Development
-
Plants, Genetically Modified / growth & development
-
Rabies Vaccines / biosynthesis
-
Recombinant Proteins / biosynthesis
-
Recombinant Proteins / immunology
-
Technology Transfer
-
Tuberculosis Vaccines / biosynthesis
-
Vaccines / biosynthesis*
Substances
-
AIDS Vaccines
-
Adjuvants, Immunologic
-
Antibodies, Monoclonal
-
Antigen-Antibody Complex
-
Rabies Vaccines
-
Recombinant Proteins
-
Tuberculosis Vaccines
-
Vaccines